What Has Been the Growth Trajectory of the Hemoglobin A1c Testing Devices Market?
The hemoglobin a1c testing devices market has seen considerable growth due to a variety of factors.
• In the past few years, the hemoglobin a1c testing devices market has exhibited fast-paced growth. The market size is predicted to expand from $1.88 billion in 2024 to $2.09 billion in 2025, marking a compound annual growth rate (CAGR) of 11.1%. This growth in the previous period is attributed to comprehensive diabetes management programs, constant innovation, enhancements in healthcare infrastructure, preventive healthcare measures, and the emergence of home healthcare trends.
What Can Be Expected from the Hemoglobin A1c Testing Devices Market Size?
The Hemoglobin A1c Testing Devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, the market size of hemoglobin a1c testing devices is projected to experience swift growth, expanding to $3.24 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%.
Factors contributing to this growth during the forecast period involve the expansion of point-of-care testing, the surge in home testing and self-monitoring, a keen focus on preventive healthcare, the rise in the elderly population, and the broadening access to healthcare services. Key trends during the projection period encompass continuous innovation coupled with cost effectiveness, increasing incidence of diabetes, a shift towards point-of-care testing, advances in technology, and the rise of home healthcare along with self-monitoring.
What Are the Critical Driver Fuelling The Hemoglobin A1c Testing Devices Market's Growth?
The escalating incidence of diabetes is anticipated to boost the expansion of the hemoglobin A1C testing devices market. Diabetes, a long-lasting metabolic disorder, raises the levels of glucose in the blood. Hemoglobin A1C testing plays a role in delivering information on a person's mean blood glucose levels, which are used to diagnose type 2 diabetes, pre-diabetes, and in managing diabetes, aiding individuals to observe their disease and make treatment choices to avoid complications. As an example, in 2022, around 37.3 million people, or 11.3% of the United States population, were reported to have diabetes by the Centers for Disease Control and Prevention, a national public health institution based in the US. Therefore, the rise in the number of diabetes patients will stimulate growth in the hemoglobin A1C testing devices market.
How Is The Hemoglobin A1c Testing Devices Market segmented?
The hemoglobin A1c testing devices market covered in this report is segmented –
1) By Type: Bench Top Device, Handheld Device
2) By Technology: Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Other Technologies
3) By End Use: Hospitals, Pharmaceuticals, Medical Devices, Laboratory Testing
Subsegments:
1) By Bench Top Device: Automated Hemoglobin A1C Analyzers, Laboratory-Grade Analyzers, Multi-Parameter Testing Devices
2) By Handheld Device: Portable Hemoglobin A1C Testers, Point-Of-Care Testing Devices, Smartphone-Integrated Testing Devices
Pre-Book The Hemoglobin A1c Testing Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Hemoglobin A1c Testing Devices Market?
Leading firms in the hemoglobin A1C testing devices market are concentrating on creating innovative solutions like at-home HbA1c test kits in order to grant patients more autonomy over their diabetes management. The term at-home HbA1c test kit pertains to a medical tool engineered for individuals to check their hemoglobin A1c (HbA1c) levels at their own convenience and environment. For example, OmegaQuant, LLC, an independent US-based CLIA-certified lab, introduced a novel HbA1c test in May 2022 that allows people to effectively keep track of their blood sugar levels at home. This at-home test kit lets users draw a blood sample with a basic finger prick, offering insights into their average blood glucose levels for the preceding three months. The test results, which display ideal ranges for managing healthy blood sugar levels, supply users with the knowledge to make well-informed decisions regarding their diet and lifestyle.
Who Are the Key Players In The Hemoglobin A1c Testing Devices Market?
Major companies operating in the hemoglobin A1c testing devices market include:
• Arkray Inc
• Abbott Laboratories
• Polymer Technology Systems Inc
• Bio-Rad Laboratories Inc
• Menarini Group
• F Hoffmann-La Roche AG
• Siemens Healthineers AG
• Tosoh Corporation
• Trinity Biotech plc
• Transasia Bio-Medicals Limited
• Beckman Coulter Inc
• Diazyme Laboratories Inc
• EKF Diagnostics Holdings plc
• HemoCue AB
• OSANG Healthcare Co Ltd
• Danaher
• Bayer AG
• Thermo Fisher Scientific Inc.
• PTS Diagnostics India Private Limited
• Nova Biomedical
• Randox Laboratories Ltd.
• ACON Laboratories Inc.
• DiaSys Diagnostic Systems GmbH
• Erba Mannheim
• Green Cross Medical Science Corp.
• Infopia Co. Ltd.
• TaiDoc Technology Corporation
• Werfen
• Zhejiang Orient Gene Biotech Co. Ltd.
What Is The Most Dominant Region In The Hemoglobin A1c Testing Devices Market?
North America was the largest region in the hemoglobin A1C testing devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the hemoglobin A1C testing devices market during the forecast period. The regions covered in the hemoglobin a1c testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
